跳至主要内容
临床试验/NCT05440994
NCT05440994Unknown不适用

Phenotypic Description of Patients With Atypical Clinical Forms of PLA2G6 Mutations

University Hospital, Clermont-Ferrand7 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
7
主要终点
Birth term in gestational weeks

研究概览

简要总结

Mutations in the PLA2G6 gene are well known in the classical phenotype called infantile neuro-axonal dystrophy (INAD), a severe neurodegenerative disease starting in infancy with homogeneous clinical, radiological, electrophysiological and pathophysiological features, with early death. Other clinical forms in pediatric patients called atypic INAD have been described in some patients. Expansion of high-throughput sequencing in the last decades has lead to identify mutations in the PLA2G6 gene in pediatric patients with late-onset phenotypes associating progressive ataxia, spastic paraplegia, cognitive regression and/or dystonia / parkinsonism. A high variability in radiological and electrophysiological findings is also described. Less than twenty patients with a pediatric onset have been reported with an atypical INAD. Very poor data are available on management and therapeutic options in these patients and global prognostic is not known. This multicentric retrospective study will record clinical, radiological, electrophysiological and pathophysiological data in pediatric patients with genetically confirmed atypical INAD. Management, therapeutics and evolution of the disease will also be recorded.

详细描述

Patients with biallelic mutations in PLA2G6 with an atypic INAD starting before 18 years will be recruited after a collaboration call of neuropaediatricians in France. After family consent, a retrospective collection of data will be performed using REDCap® digital questionnaire performed by the practitioner who follows / followed each patient.

Genetical, clinical, radiological, electrophysiological, pathophysiological outcomes will be anonymously recorded. Therapeutics proposed to patients, potential complications of the disease or treatments, age of premature death will also be recorded.

Data will be computed numerically and analysed in the Clermont-Ferrand center. A descriptive analysis will be proposed as the expected number of patients affected by this rare disease varies from 10 to 30. Median []interquartiles], means [standard deviation] and percentages will be calculated for quantitative data.

Collected data will include :

  • general information :

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Children with atypical neuroaxonal dystrophy under 18 years at disease-onset
  • with 2 deleterious mutations in the PLA2G6 gene
  • alive or deceased
  • Non-opposition of parents to participate to the retrospective study

排除标准

  • Classical form of infantile neuroaxonal dystrophy
  • Neuro-axonal dystrophy with adult-onset
  • Opposition of parents to participate to the retrospective study

结局指标

主要结局

Birth term in gestational weeks

时间窗: through study completion, an average of 9 months

quantitative feature, number of gestational weeks

Age at walking in years and months

时间窗: through study completion, an average of 9 months

quantitative feature, age in years and months

Acquisition of fine motor skills

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No

Neurological regression

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type of regression (language, motor, social, hearing, visual)

Age at sitting in months

时间窗: through study completion, an average of 9 months

quantitative feature, age in months

Autistic troubles

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No

Progressivity of symptoms

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No

Seizures

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset

Intellectual deficiency

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of severity (mild, moderate, severe, profound)

Pyramidal signs

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (spasticity, Babinski, hyperreflexia, other)

Age at first language in years and months

时间窗: through study completion, an average of 9 months

quantitative feature, age in years and months

Axial hypotonia

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No

Peripheral neurological signs

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (myopathy, neuropathy, areflexia, bulbar signs, other)

Movement disorders

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (dystonia, paroxysmal dyskinesia, parkinsonism, nystagmus, ataxia, other)

Radiological abnormalities

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (Iron deposits, White matter abnormalities, Cerebellar atrophy, Optic nerve atrophy, Brainstem atrophy, Cortical-subcortical atrophy, Splenium verticalization, Other abnormalities of corpus callosum, Clava hypertrophy, Other)

Gastro-intestinal disorders

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type

Behavioral or mood disorders

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type

Sleep disorders

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type

Visual abnormalities

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (strabism, nystagmus, eye fundus abnormalities, other)

GMFCS

时间窗: through study completion, an average of 9 months

GMFCS scoring from 1 to 5

Orthopaedic disorders

时间窗: through study completion, an average of 9 months

Qualitative feature, answer :Yes / No Precision of age at onset Precision of type (scoliosis, hip, ankle deformations, other)

次要结局

  • Therapeutics(through study completion, an average of 9 months)
  • Phenotype-genotype correlation(through study completion, an average of 9 months)
  • Mutations in PLA2G6(through study completion, an average of 9 months)
  • Electrophysiological findings(through study completion, an average of 9 months)
  • Pathophysiological findings(through study completion, an average of 9 months)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验